Daniel A. Holterman, Ph.D. - Publications

Affiliations: 
2003 Old Dominion University, Norfolk, VA, United States 
Area:
Immunology, Oncology

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Gatalica Z, Snyder C, Maney T, Ghazalpour A, Holterman DA, Xiao N, Overberg P, Rose I, Basu GD, Vranic S, Lynch HT, Von Hoff DD, Hamid O. Programmed cell death 1 (PD-1) and its ligand (PD-L1) in common cancers and their correlation with molecular cancer type. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 2965-70. PMID 25392179 DOI: 10.1158/1055-9965.EPI-14-0654  0.336
2014 Gatalica Z, Snyder CL, Yeatts K, Xiao N, Holterman D, Lynch HT. Programmed death 1 (PD-1) lymphocytes and ligand (PD-L1) in colorectal cancer and their relationship to microsatellite instability status. Journal of Clinical Oncology. 32: 3625-3625. DOI: 10.1200/Jco.2014.32.15_Suppl.3625  0.303
2012 Smith SE, Holterman DA, Brown KM, Duncan JE, Zhong J, Stark A, Millis M, Tinder T, Spetzler D. Abstract 3607: Differential protein expression and miR content of sorted subsets of circulating microvesicles from cancer patients and healthy controls Cancer Research. 72: 3607-3607. DOI: 10.1158/1538-7445.Am2012-3607  0.31
2011 Deng T, Spetzler DB, Holterman D, Pawlowski T, Duncan JE, Smith SE, Radebach K, LIttle T, Kuslich CD. Abstract 444: Subpopulations of circulating microvesicles have different microRNA profiles Cancer Research. 71: 444-444. DOI: 10.1158/1538-7445.Am2011-444  0.301
2011 Spetzler DB, Deng T, Tinder T, Kimbrough J, Ellis P, Holterman D, Maney T, Kuslich CD. Abstract 4060: Enriching for rrare subpopulations of circulating microvesicles by the depletion of endothelial- and leukocyte-derived microvesicles Cancer Research. 71: 4060-4060. DOI: 10.1158/1538-7445.Am2011-4060  0.354
2011 Holterman DA, Duncan JE, Deng T, Smith SE, Spetzler DB, Kuslich CD. Abstract 1568: Plasma-derived circulating microvesicles can both detect and help monitor breast cancer-related pathologies Cancer Research. 71: 1568-1568. DOI: 10.1158/1538-7445.Am2011-1568  0.371
2006 Holterman DA, Diaz JI, Blackmore PF, Davis JW, Schellhammer PF, Corica A, Semmes OJ, Vlahou A. Overexpression of alpha-defensin is associated with bladder cancer invasiveness. Urologic Oncology. 24: 97-108. PMID 16520271 DOI: 10.1016/J.Urolonc.2005.07.010  0.349
2004 Ciavarra RP, Holterman DA, Brown RR, Mangiotti P, Yousefieh N, Wright GL, Schellhammer PF, Glass WF, Somers KD. Prostate tumor microenvironment alters immune cells and prevents long-term survival in an orthotopic mouse model following flt3-ligand/CD40-ligand immunotherapy. Journal of Immunotherapy (Hagerstown, Md. : 1997). 27: 13-26. PMID 14676630 DOI: 10.1097/00002371-200401000-00002  0.575
2003 Ciavarra RP, Brown RR, Holterman DA, Garrett M, Glass WF, Wright GL, Schellhammer PF, Somers KD. Impact of the tumor microenvironment on host infiltrating cells and the efficacy of flt3-ligand combination immunotherapy evaluated in a treatment model of mouse prostate cancer. Cancer Immunology, Immunotherapy : Cii. 52: 535-45. PMID 14627125 DOI: 10.1007/S00262-003-0383-X  0.69
2003 Somers KD, Brown RR, Holterman DA, Yousefieh N, Glass WF, Wright GL, Schellhammer PF, Qian J, Ciavarra RP. Orthotopic treatment model of prostate cancer and metastasis in the immunocompetent mouse: efficacy of flt3 ligand immunotherapy. International Journal of Cancer. Journal International Du Cancer. 107: 773-80. PMID 14566827 DOI: 10.1002/Ijc.11464  0.56
Show low-probability matches.